|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.51 USD | -2.07% |
|
-3.24% | -19.40% |
| 06/03 | Tenaya Therapeutics and Alnylam Pharmaceuticals Enter Research Collaboration Agreement | CI |
| 05/03 | Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments | RE |
Quotes 5-day view: Alnylam Pharmaceuticals, Inc.
Delayed Quote Nasdaq| 27/02/2026 | 02/03/2026 | 03/03/2026 | 04/03/2026 | 05/03/2026 | |
|---|---|---|---|---|---|
| Last | 332.92 $ | 325.07 $ | 318.65 $ | 327.30 $ | 320.51 $ |
| Volume | 15,69,839 | 13,02,332 | 9,47,625 | 9,31,151 | 12,15,172 |
| Change | +0.51% | -2.36% | -1.97% | +2.71% | -2.07% |
| Opening | 331.24 $ | 329.41 $ | 321.37 $ | 319.20 $ | 323.69 $ |
| High | 334.80 $ | 334.42 $ | 324.06 $ | 328.00 $ | 328.28 $ |
| Low | 328.39 $ | 323.16 $ | 315.20 $ | 317.25 $ | 319.51 $ |
Performance
| 1 day | -2.07% | ||
| 1 week | -3.24% | ||
| Current month | -3.73% | ||
| 1 month | -3.24% | ||
| 3 months | -30.04% | ||
| 6 months | -29.09% | ||
| Current year | -19.40% | ||
| 1 year | +28.60% | ||
| 3 years | +58.21% | ||
| 5 years | +123.52% | ||
| 10 years | +441.58% |
Volumes
marketsDaily volume
12,15,172
Estimated daily volume
12,15,172
Avg. Volume 20 sessions
12,52,606
Daily volume ratio
0.97
Avg. Volume 20 sessions USD
40,14,72,749.06
Record volume 1
1,83,62,420
Record volume 2
1,67,31,380
Record volume 3
1,25,76,505
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
42,50,70,43,883
Net sales (USD)
3,71,39,37,000
Number of employees
2,500
Sales / Employee (USD)
14,85,575
Free-Float
99.2 %
Free-Float capitalization (USD)
41,16,18,42,900
Average Daily Capital Traded
0.94%
Indicators
Moving average 5 days
327.04
Moving average 20 days
328.25
Moving average 50 days
358.16
Moving average 100 days
402.35
Price spread / (MMA5)
+2.04%
Price spread / (MMA20)
+2.42%
Price spread / (MMA50)
+11.75%
Price spread / (MMA100)
+25.54%
STIM
RSI 9 days
46.24
RSI 14 days
43.47
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.07% | -3.24% | +28.60% | +58.21% | 4.25TCr | ||
| -2.02% | -3.79% | +5.76% | +208.78% | 88TCr | ||
| -2.31% | -1.58% | +45.12% | +55.58% | 58TCr | ||
| -1.63% | +3.41% | +9.84% | +48.89% | 41TCr | ||
| -2.93% | -7.03% | +12.72% | +26.04% | 36TCr | ||
| -0.70% | -5.49% | +22.12% | +36.73% | 30TCr | ||
| -1.74% | -5.99% | +23.33% | +54.86% | 30TCr | ||
| -3.50% | -2.71% | +24.55% | +8.60% | 29TCr | ||
| -3.08% | -3.09% | +16.12% | +56.55% | 20TCr | ||
| -2.08% | +0.95% | +25.73% | +79.03% | 18TCr | ||
| Average | -1.69% | -1.33% | +21.39% | +63.33% | 35.42TCr | |
| Weighted average by Cap. | -1.39% | -1.63% | +19.66% | +85.60% |
Historical Quotes: Alnylam Pharmaceuticals, Inc.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
5e9b065c918.ChcyiX2_Ozu21-ujASZ62Qht_z7GupPV2QAtRbnFFa4.WlVV6CmMD27D4d7PSBcjuF4mi0m-8NSirnBmMP-zR89CTkXoKt1zbcSVgA
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:30:00 am | 320.51 | 1,20,942 | 8,32,825 |
| 02:30:00 am | 320.76 | 100 | 7,11,883 |
| 02:30:00 am | 320.74 | 74 | 7,11,783 |
| 02:29:59 am | 320.42 | 207 | 7,11,709 |
| 02:29:59 am | 320.44 | 100 | 7,11,502 |
| 02:29:59 am | 320.69 | 40 | 7,11,402 |
| 02:29:59 am | 320.44 | 58 | 7,11,362 |
| 02:29:59 am | 320.58 | 44 | 7,11,304 |
| 02:29:59 am | 320.55 | 54 | 7,11,260 |
| 02:29:59 am | 320.44 | 225 | 7,11,206 |
Course Extremes
| 1 week | 315.2 | 334.42 | |
| 1 month | 298 | 345.9 | |
| Current year | 298 | 427.05 | |
| 1 year | 205.87 | 495.55 | |
| 3 years | 141.98 | 495.55 | |
| 5 years | 117.58 | 495.55 | |
| 10 years | 31.38 | 495.55 |
Monthly variations
Annual variations
| 2026 | -19.40% | ||
| 2025 | +68.99% | ||
| 2024 | +22.94% | ||
| 2023 | -19.46% | ||
| 2022 | +40.14% | ||
| 2021 | +30.48% | ||
| 2020 | +12.85% | ||
| 2019 | +57.96% | ||
| 2018 | -42.61% | ||
| 2017 | +239.34% | ||
| 2016 | -60.23% | ||
| 2015 | -2.95% | ||
| 2014 | +50.86% | ||
| 2013 | +252.33% | ||
| 2012 | +123.93% | ||
| 2011 | -17.34% | ||
| 2010 | -44.04% | ||
| 2009 | -28.75% | ||
| 2008 | -14.96% | ||
| 2007 | +35.89% | ||
| 2006 | +60.18% | ||
| 2005 | +78.85% | ||
| 2004 | +24.29% |
- Stock Market
- Equities
- ALNY Stock
- Quotes Alnylam Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















